Skip to main content
Log in

Vitamin D Deficiency and Insulin Resistance in Normal and Type 2 Diabetes Subjects

  • Original Research
  • Published:
Indian Journal of Clinical Biochemistry Aims and scope Submit manuscript

Abstract

Vitamin D is recognized to serve a wide range of biological functions. The presence of vitamin D receptors on different tissues explains it’s diversity of actions. Reduced levels of vitamin D is associated with insulin resistance and increased diabetes risk. The study included 50 normal healthy individuals and 49 type 2 diabetes subjects. Fasting blood glucose, total cholesterol, triglycerides, HDLc, fasting insulin, parathyroid hormone, calcium, albumin and Homeostasis model for assessment of insulin resistance (HOMAIR) were measured in all the study participants. Type 2 diabetes subjects were divided into group 1 with 25 hydroxy vitamin D (25(OH)D) ≤20 ng/ml and group 2 with 25(OH)D >20 ng/ml. By the results of this study, the mean 25(OH)D level was low (20.09 ng/ml) in type 2 diabetes compared to controls (23.89 ng/ml) and the p value was 0.02. The estimated insulin resistance by HOMAIR was more in group 1 than in group 2 of diabetes with p value of 0.037. The Pearson’s correlation-coefficient was negative for 25(OH)D and insulin in type 2 diabetes (r = −0.294), 25(OH)D was negatively correlated with HOMAIR in total subjects. Type 2 diabetes subjects had reduced levels of vitamin D than normal individuals. The insulin resistance was more in vitamin D deficiency state. Hence vitamin D has a role in glucose metabolism, deficiency can result in insulin resistance and diabetes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Kochhupalli N. The physiology of vitamin D. Indian J Med Res. 2008;127:256–62.

    Google Scholar 

  2. Nagapal S, Na S, Rathnachalam R. Noncalcemic actions of vitamin D receptor ligands. Endocr Rev. 2005;26:662–7.

    Article  Google Scholar 

  3. Zittermann A. Vitamin D in preventive medicine: are we ignoring the evidence? Br J Nutr. 2003;89(5):55–72.

    Article  Google Scholar 

  4. Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357:266–81.

    Article  PubMed  CAS  Google Scholar 

  5. Takiishi T, Gysemans C, Bouillon R, Mathieu C. Vitamin D and diabetes. Rheum Dis Clin North Am. 2012;38(1):179–206.

    Article  PubMed  Google Scholar 

  6. Paul K, Maarit L, Catharina M, Tommi H, Jukka M, H Markku, et al. Serum vitamin D and subsequent occurrence of type 2 diabetes. Epidemiology. 2008;19(5):666–71.

    Article  Google Scholar 

  7. Pittas AG, Sun Q, Manson JE, Dawson-Hughes B, Hu FB. Plasma 25-hydroxy vitamin D concentration and risk of incident type 2 diabetes in women. Diabetes Care. 2010;33:2021–3.

    Article  PubMed  CAS  Google Scholar 

  8. Ramachandran A, Snehalatha C. Current scenario of diabetes in India. J Diabetes. 2009;1(1):18–28.

    Article  PubMed  Google Scholar 

  9. Mohan V, Sandeep S, Deepa R, Shah B, Vrghese C. Epidemiology of type 2 diabetes: Indian scenario. Indian J Med Res. 2007;125:217–30.

    PubMed  CAS  Google Scholar 

  10. Hodgkin P, Hine PM, Kay GH, Lumb GA, Stanbury SW. Vitamin D deficiency in Asians at home and in Britain. Lancet. 1973;302:167–72.

    Article  Google Scholar 

  11. Harinarayan CV, Gupta N, Kochupillai N. Vitamin D status in primary hyperparathyroidism in India. Clin Endocrinol. 1995;43:351–8.

    Article  CAS  Google Scholar 

  12. Goswami R, Gupta N, Goswami D, Marwaha RK, Tandon N, Kochupillai N. Prevalence and significance of low 25-hydroxy vitamin D concentration in healthy subjects in Delhi. Am J Clin Nutr. 2000;72:472–5.

    PubMed  CAS  Google Scholar 

  13. Harinarayan CV, Ramalakshmi T, Prasad UV, Sudhakar D, Srinivasarao PVLN, Sarma KVS, et al. High prevalence of low dietary calcium, high phytate consumption, and vitamin D deficiency in healthy south Indians. Am J Clin Nutr. 2007;85:1062–7.

    PubMed  CAS  Google Scholar 

  14. Harinarayan CV. Prevalence of vitamin D insufficiency in postmenopausal south Indian women. Osteoporos Int. 2005;16:397–402.

    Article  PubMed  CAS  Google Scholar 

  15. Harinarayan CV, Ramalakshmi T, Prasad UV, Sudhakar D. Vitamin D status in Andhra Pradesh: a population based study. Indian J Med Res. 2008;127:211–8.

    PubMed  CAS  Google Scholar 

  16. Harinarayan CV, Ramalakshmi T, Venkata Prasad U. High prevalence of low dietary calcium and low vitamin D status in healthy South Indians. Asia Pac J Clin Nutr. 2004;13:359–64.

    PubMed  CAS  Google Scholar 

  17. Chiu KC, Chu A, Go VLW, Saad MF. Hypovitaminosis D is associated with insulin resistance and β cell dysfunction. Am J Clin Nutr. 2004;79:820–5.

    PubMed  CAS  Google Scholar 

  18. Pittas AG, Lau J, Hu FB, Dawson-Hughes B. The role of vitamin D and calcium in type 2 diabetes. a systematic review and meta-analysis. J Clin Endocrinol Metab. 2007;92:2017–29.

    Article  PubMed  CAS  Google Scholar 

  19. scragg R, Sowers M, Bell C. Serum 25-hydroxy vitamin D, diabetes and ethnicity in the third national health and nutrition examination survey. Diabetes Care. 2004;27:2813–8.

    Article  PubMed  CAS  Google Scholar 

  20. Ford ES, Ajani UA, McGuire LC, Liu S. Concentration of serum vitamin D and the metabolic syndrome among US adults. Diabetes Care. 2005;28:1228–30.

    Article  PubMed  CAS  Google Scholar 

  21. Bourlon PM, Billaudel B. Dussert. Influence of Vitami D3 deficiency and 1,25 dihydroxy D3 on denovo insulin biosynthesis in islets of the rat endocrine pancreas. J Endocrinol. 1999;160:87–95.

    Article  PubMed  CAS  Google Scholar 

  22. Danescu LG, Levy S, Levy J. Vitamin D and diabetes mellitus. Endocrine. 2009;35:11–7.

    Article  PubMed  CAS  Google Scholar 

  23. Giulietti A, Van Etten E, Overbergh L, Stoffels K, Bouillon R, Mathieu C. Monocytes from type 2 diabetic patients have a pro-inflammatory profile: 1,25-dihydroxy vitamin D3 works as anti inflammatory. Diabetes Res Clin Pract. 2007;77(1):47–57.

    Article  PubMed  CAS  Google Scholar 

  24. Cohen-Lahav M, Douvdevani A, Chaimovitz C, Shany S. The anti inflammatory activity of 1,25 dihydroxy vitamin D3 in macrophages. J Steroid Biochem Mol Biol. 2007;103:558–62.

    Article  PubMed  CAS  Google Scholar 

  25. Saxe AW, Gibson G, Gingerich RL, Levy J. Parathyroid hormone decreases in vivo insulin effect on glucose utilization. Calcif Tissue Int. 1995;57:127–32.

    Article  PubMed  CAS  Google Scholar 

  26. Teegarden D, Donkin SS. Vitamin D: emerging new roles in insulin sensitivity. Nutr Res Rev. 2009;22:82–92.

    Article  PubMed  CAS  Google Scholar 

  27. Ling L, Zhijie Y, Pan A, Hu FB, Franco OH, Li H, et al. Plasma 25-hydroxy vitamin D concentration and metabolic syndrome among middle-aged and elderly Chinese individuals. Diabetes Care. 2009;32:1278–83.

    Article  Google Scholar 

  28. Bonora E, Formentini G, Calcaterra F, Lombardi S, Marini F, Zenari L, et al. HOMA estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetes subjects. Diabetes Care. 2002;25(7):135–41.

    Article  Google Scholar 

  29. Harinarayan CV, Joshi SR. Vitamin D status in India—its implications and remedial measures. J Assoc Physicians India. 2009;57:40–8.

    PubMed  CAS  Google Scholar 

  30. Gagnon C, Lu ZX, Magliano DJ, Dunstan DW, Shaw JE, Zimmet PZ, et al. Serum 25-hydroxy vitamin D, calcium intake, and risk of type 2 diabetes after 5 years: results from a national, population-based prospective study (the Australian diabetes, obesity and lifestyle study). Diabetes Care. 2011;34:1133–8.

    Article  PubMed  CAS  Google Scholar 

  31. Bischoff HA, Borchers M, Gudat F, Duermueller U, Theiler R, et al. In situ detection of 1, 25 dihydroxy vitamin D receptor in human skeletal muscle tissue. Histochem J. 2001;33(1):19–24.

    Article  PubMed  CAS  Google Scholar 

  32. Alvarez JA, Ashraf A. Role of Vitamin D in Insulin secretion and insulin sensitivity for glucose homeostasis. Int J Endocrinol. 2010;2010:1–18.

    Article  Google Scholar 

  33. Norman AW. Vitamin D receptor: new assignments for an already busy receptor. Endocrinology. 2006;147:5542–8.

    Article  PubMed  CAS  Google Scholar 

  34. Li J, Byrne ME, Chang E, Jiang Y, Donkin SS, Buhman KK, et al. 1α,25 Dihydroxy vitamin D hydroxylase in adipocytes. J Steroid Biochem Mol Biol. 2008;112:122–6.

    Article  PubMed  CAS  Google Scholar 

  35. Ogunkolade BW, Boucher BJ, Prahl JM. Vitamin D receptor (VDR) mRNA and VDR protein levels in relation to vitamin D status, insulin secretory capacity, and VDR genotype in Bangladeshi Asians. Diabetes. 2002;51:2294–300.

    Article  PubMed  CAS  Google Scholar 

  36. Calle C, Maestro B. Garcia–arencibia M. Genomic actions of 1,25-dihydroxy vitamin D3 on insulin receptor gene expression, insulin receptor number and insulin activity in kidney, liver and functions: VDRs, gene expression, and insulin secretion. Endocrinology. 1994;134:1602–10.

    Article  Google Scholar 

  37. Nita G, Luan J, Cooper A, Boucher BJ, Wareham NJ. Baseline 25 hydroxy vitamin D is predictive of future glycemic status and Insulin resistance. The medical research council Ely prospective study—1990–2000. Diabetes. 2008;57(10):2619–25.

    Article  Google Scholar 

  38. Pinelli NR, Jaber LA, Brown MB, Herman WH. Serum 25-hydroxy vitamin D and Insulin resistance, metabolic syndrome, and glucose intolerance among Arab Americans. Diabetes Care. 2010;33:1373–5.

    Article  PubMed  CAS  Google Scholar 

  39. Rathi N, Rathi A. Vitamin D and child health in the 21st century. Indian Pediatr. 2011;48:619–25.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sowjanya Bachali.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bachali, S., Dasu, K., Ramalingam, K. et al. Vitamin D Deficiency and Insulin Resistance in Normal and Type 2 Diabetes Subjects. Ind J Clin Biochem 28, 74–78 (2013). https://doi.org/10.1007/s12291-012-0239-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12291-012-0239-2

Keywords

Navigation